Lear heads into Q3 print with analysts cutting targets and shorts retreating

Positioning in the lending market tells a different story from the Street's caution. Short interest has fallen sharply, dropping around 21% over the past month to 3.6% of the free float, a level that is modest for an automotive supplier facing genuine cyclical questions. Borrow conditions confirm the retreat: cost to borrow has eased to roughly 0.44%, down 37% on the week, and availability is extremely loose at 2,560% of short interest, meaning there are roughly 25 shares available to borrow for every one already shorted. That is far from any squeeze dynamic. The ORTEX short score has also drifted lower, from around 39.7 in late September to 36.4 now, moving in the direction of less bearish conviction rather than more. Options lean mildly more defensive than usual: the put/call ratio is at 0.47, about 1.2 standard deviations above its 20-day average of 0.42, but the absolute level is far from alarming and sits well below the 52-week high of 1.29. The overall picture in derivatives is one of modest hedging, not panic.

On the insider register, the recent signal is net negative but the amounts are modest at this stage. A director sold 1,646 shares in August for roughly $200,000. Earlier in the summer, CEO Raymond Scott sold over $5.7 million worth of stock across multiple tranches on June 24, none of them declared under a 10b5-1 plan. Those discretionary sales happened at prices between $134 and $137, above where the stock trades today. There is no buying on record in the 90-day window. The net 90-day figure is a sale of 1,646 shares worth just under $200,000, the CEO's June activity sitting outside that window, but its absence of a pre-arranged plan is worth noting. On the institutional side, BlackRock added 325,706 shares through September and Dimensional added 76,686, while Pzena remains the largest holder at 13.5% of shares. No 13D activist has appeared on the register.

Earnings history underscores what is at stake on October 26. The July 31 print was damaging: the stock fell 14.5% on the day and extended to a 16% loss over five days. The prior quarter's report showed a 1.7% gain on the day followed by a 13% decline over the following week. That pattern, sharp reactions in both directions with losses widening on the five-day horizon, tells the story of a stock the market is willing to punish quickly when results disappoint, and where post-earnings relief rallies have not held. The stock is already down 9% over the past month, so some of the anxiety may already be priced in. Close peer Adient added about 2% on the week and Continental gained nearly 4%, suggesting the broader supplier group held up reasonably well while LEA lagged slightly.

With the print 19 days away, what shifts the story is less the lending data (which is benign) and more whether the October 26 release can break the pattern of post-earnings deterioration that has defined the stock since the summer.